{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:16:13Z","timestamp":1790151373126,"version":"4.0.1"},"reference-count":83,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Central precocious puberty (CPP) classically refers to premature activation of the hypothalamic\u2013pituitary\u2013gonadal axis with onset of sexual development before the age of 8 years in girls and 9 years in boys. A decrease in the age of thelarche has been reported over the past several decades; however, the tempo of pubertal progression can be slower and adult height may not be adversely affected in many of the girls who experience thelarche at 6-8 years. Outside of this secular trend in the development itself, the past several decades have also brought about advances in diagnosis and management. This includes the widespread use of an ultrasensitive luteinizing hormone assay, decreasing the need for stimulation testing and a better understanding of the genetics that govern the onset of puberty. Additionally, management of CPP using gonadotropin-releasing hormone analogs (GnRHas) has changed with the advent of new longer-acting formulations. Emerging long-term outcomes of GnRHa administration with regards to obesity, cardiovascular risk factors and fertility are reassuring. Despite these advancements, clinical care in CPP is hampered by the lack of well-designed controlled studies, and management decisions are frequently not supported by clear practice guidelines. Data in boys with CPP are limited and this article focuses on the diagnosis and management of CPP in girls, particularly, in those who present with thelarche at the age of 6-8 years.<\/jats:p>","DOI":"10.1210\/clinem\/dgad081","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T07:26:39Z","timestamp":1678778799000},"page":"2115-2123","source":"Crossref","is-referenced-by-count":37,"title":["Approach to the Patient: Central Precocious Puberty"],"prefix":"10.1210","volume":"108","author":[{"given":"Marissa J","family":"Kilberg","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Endocrinology and Diabetes , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1941-8277","authenticated-orcid":false,"given":"Maria G","family":"Vogiatzi","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Endocrinology and Diabetes , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"issue":"5","key":"2023071417192868200_dgad081-B1","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13141","article-title":"The fifty years following the discovery of gonadotropin-releasing hormone","volume":"34","author":"Plant","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"22","key":"2023071417192868200_dgad081-B2","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMcp0800459","article-title":"Clinical practice. Precocious puberty","volume":"358","author":"Carel","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"2023071417192868200_dgad081-B3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1542\/peds.99.4.505","article-title":"Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network","volume":"99","author":"Herman-Giddens","year":"1997","journal-title":"Pediatrics"},{"issue":"6","key":"2023071417192868200_dgad081-B4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1542\/peds.2012-3773","article-title":"Onset of breast development in a longitudinal cohort","volume":"132","author":"Biro","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"2023071417192868200_dgad081-B5","doi-asserted-by":"crossref","first-page":"e932-9","DOI":"10.1542\/peds.2008-2491","article-title":"Recent decline in age at breast development: the Copenhagen Puberty Study","volume":"123","author":"Aksglaede","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"2023071417192868200_dgad081-B6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.2008-0146","article-title":"Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index","volume":"123","author":"Rosenfield","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"2023071417192868200_dgad081-B7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/EJE-18-0473","article-title":"GnRH analog is ineffective in increasing adult height in girls with puberty onset after 7 years of age: a systematic review and meta-analysis","volume":"179","author":"Franzini","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023071417192868200_dgad081-B8","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2019.5881","article-title":"Worldwide secular trends in age at pubertal onset assessed by breast development among girls: a systematic review and meta-analysis","volume":"174","author":"Eckert-Lind","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"4","key":"2023071417192868200_dgad081-B9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1542\/peds.104.4.936","article-title":"Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society","volume":"104","author":"Kaplowitz","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"2023071417192868200_dgad081-B10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jpag.2018.05.002","article-title":"Age of menarche in a longitudinal US cohort","volume":"31","author":"Biro","year":"2018","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"2023071417192868200_dgad081-B11","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/apa.15092","article-title":"The tempo of puberty and its relationship to adolescent health and well-being: A systematic review","volume":"109","author":"Cheng","year":"2020","journal-title":"Acta Paediatr"},{"issue":"6","key":"2023071417192868200_dgad081-B12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000501336","article-title":"Use of gonadotropin-releasing hormone analogs in children: update by an international consortium","volume":"91","author":"Krishna","year":"2019","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"2023071417192868200_dgad081-B13","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab173","article-title":"An approach to the evaluation and management of the obese child with early puberty","volume":"6","author":"Tenedero","year":"2022","journal-title":"J Endocr Soc"},{"issue":"11","key":"2023071417192868200_dgad081-B14","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/obr.12587","article-title":"Birth weight, early life weight gain and age at menarche: a systematic review of longitudinal studies","volume":"18","author":"Juul","year":"2017","journal-title":"Obes Rev"},{"issue":"6","key":"2023071417192868200_dgad081-B15","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1210\/clinem\/dgab092","article-title":"Longitudinal investigation of pubertal milestones and hormones as a function of body fat in girls","volume":"106","author":"Ortega","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071417192868200_dgad081-B16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1210\/clinem\/dgab064","article-title":"Total and central adiposity are associated with age at gonadarche and incidence of precocious gonadarche in boys","volume":"106","author":"Pereira","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071417192868200_dgad081-B17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13052-021-01015-6","article-title":"Impact of COVID-19 pandemic lockdown on early onset of puberty: experience of an Italian tertiary center","volume":"47","author":"Verzani","year":"2021","journal-title":"Ital J Pediatr"},{"issue":"2","key":"2023071417192868200_dgad081-B18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1515\/jpem-2021-0565","article-title":"Increased frequency of idiopathic central precocious puberty in girls during the COVID-19 pandemic: preliminary results of a tertiary center study","volume":"35","author":"Acar","year":"2022","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"2023071417192868200_dgad081-B19","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1210\/jc.2010-1025","article-title":"Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigration","volume":"95","author":"Soriano-Guillen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023071417192868200_dgad081-B20","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.3390\/nu13114184","article-title":"Effects on puberty of nutrition-mediated endocrine disruptors employed in agriculture","volume":"13","author":"Sakali","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"2023071417192868200_dgad081-B21","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101579","article-title":"Endocrine-disrupting chemicals and their effects on puberty","volume":"35","author":"Lopez-Rodriguez","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2023071417192868200_dgad081-B22","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-055595","article-title":"Are black girls exhibiting puberty earlier? Examining implications of race-based guidelines","volume":"150","author":"Osinubi","year":"2022","journal-title":"Pediatrics"},{"issue":"8","key":"2023071417192868200_dgad081-B23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40618-017-0627-9","article-title":"The mystery of puberty initiation: genetics and epigenetics of idiopathic central precocious puberty (ICPP)","volume":"40","author":"Leka-Emiri","year":"2017","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2023071417192868200_dgad081-B24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3345\/cep.2021.00521","article-title":"Genetic factors in precocious puberty","volume":"65","author":"Shim","year":"2022","journal-title":"Clin Exp Pediatr"},{"issue":"1","key":"2023071417192868200_dgad081-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000519039","article-title":"Genetic and epigenetic control of puberty","volume":"16","author":"Manotas","year":"2022","journal-title":"Sex Dev"},{"issue":"6","key":"2023071417192868200_dgad081-B26","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/jc.2018-02010","article-title":"DLK1 Is a novel link between reproduction and metabolism","volume":"104","author":"Gomes","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023071417192868200_dgad081-B27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.beem.2018.05.008","article-title":"Central precocious puberty: from genetics to treatment","volume":"32","author":"Aguirre","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"2023071417192868200_dgad081-B28","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1172\/JCI139586","article-title":"Makorin rings the kisspeptin bell to signal pubertal initiation","volume":"130","author":"Abbara","year":"2020","journal-title":"J Clin Invest"},{"issue":"5","key":"2023071417192868200_dgad081-B29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1210\/js.2019-00041","article-title":"MKRN3 Mutations in central precocious puberty: a systematic review and meta-analysis","volume":"3","author":"Valadares","year":"2019","journal-title":"J Endocr Soc"},{"issue":"8","key":"2023071417192868200_dgad081-B30","doi-asserted-by":"crossref","DOI":"10.1515\/jpem-2020-0014","article-title":"Association study of DLK1 in girls with idiopathic central precocious puberty","volume":"33","author":"Lee","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2023071417192868200_dgad081-B31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(95)70255-5","article-title":"Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty","volume":"127","author":"Neely","year":"1995","journal-title":"J Pediatr"},{"issue":"4","key":"2023071417192868200_dgad081-B32","doi-asserted-by":"crossref","first-page":"e752-62","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"2023071417192868200_dgad081-B33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/jc.2013-3292","article-title":"The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life","volume":"99","author":"Bizzarri","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023071417192868200_dgad081-B34","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1210\/jc.2017-01192","article-title":"Nocturnal urinary excretion of FSH and LH in children and adolescents with normal and early puberty","volume":"102","author":"Kolby","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023071417192868200_dgad081-B35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1515\/jpem-2018-0052","article-title":"Prevalence of cranial MRI findings in girls with central precocious puberty: a systematic review and meta-analysis","volume":"31","author":"Cantas-Orsdemir","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2023071417192868200_dgad081-B36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13633-016-0027-5","article-title":"Do 6-8 year old girls with central precocious puberty need routine brain imaging?","volume":"2016","author":"Kaplowitz","year":"2016","journal-title":"Int J Pediatr Endocrinol"},{"issue":"Suppl 2","key":"2023071417192868200_dgad081-B37","first-page":"33","article-title":"A critical appraisal of the effect of gonadotropin-releasing hormone analog treatment on adult height of girls with central precocious puberty","volume":"9","author":"Bereket","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"27","key":"2023071417192868200_dgad081-B38","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1097\/MD.0000000000000260","article-title":"Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis","volume":"93","author":"Li","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"2023071417192868200_dgad081-B39","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s40618-016-0486-9","article-title":"Effects and safety of combination therapy with gonadotropin-releasing hormone analogue and growth hormone in girls with idiopathic central precocious puberty: a meta-analysis","volume":"39","author":"Liu","year":"2016","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2023071417192868200_dgad081-B40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1515\/jpem-2021-0114","article-title":"Importance of individualizing treatment decisions in girls with central precocious puberty when initiating treatment after age 7 years or continuing beyond a chronological age of 10 years or a bone age of 12 years","volume":"34","author":"Vargas Trujillo","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2023071417192868200_dgad081-B41","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1703","article-title":"Age at menarche, depression, and antisocial behavior in adulthood","volume":"141","author":"Mendle","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"2023071417192868200_dgad081-B42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jadohealth.2019.06.004","article-title":"Early menarche and internalizing and externalizing in adulthood: explaining the persistence of effects","volume":"65","author":"Mendle","year":"2019","journal-title":"J Adolesc Health"},{"issue":"5","key":"2023071417192868200_dgad081-B43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000479688","article-title":"One-year follow-up of girls with precocious puberty and their mothers: do psychological assessments change over time or with treatment?","volume":"88","author":"Schoelwer","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"2023071417192868200_dgad081-B44","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fpsyg.2016.01053","article-title":"Cognitive, emotional, and psychosocial functioning of girls treated with pharmacological puberty blockage for idiopathic central precocious puberty","volume":"7","author":"Wojniusz","year":"2016","journal-title":"Front Psychol"},{"issue":"5","key":"2023071417192868200_dgad081-B45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/jpem-2017-0465","article-title":"Review and evaluation of patient-centered psychosocial assessments for children with central precocious puberty or early puberty","volume":"31","author":"Williams","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"2023071417192868200_dgad081-B46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/js.2019-00036","article-title":"Treatment of central precocious puberty","volume":"3","author":"Eugster","year":"2019","journal-title":"J Endocr Soc"},{"issue":"5","key":"2023071417192868200_dgad081-B47","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-65-5-946","article-title":"Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty","volume":"65","author":"Lahlou","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023071417192868200_dgad081-B48","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-2078","article-title":"Free alpha-subunit is the most sensitive marker of gonadotropin recovery after treatment of central precocious puberty with the histrelin implant","volume":"95","author":"Hirsch","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2023071417192868200_dgad081-B49","first-page":"723","article-title":"Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics","volume":"13","author":"Lahlou","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"2023071417192868200_dgad081-B50","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jpeds.2013.05.033","article-title":"A single histrelin implant is effective for 2 years for treatment of central precocious puberty","volume":"163","author":"Lewis","year":"2013","journal-title":"J Pediatr"},{"issue":"5","key":"2023071417192868200_dgad081-B51","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2265.2009.03584.x","article-title":"Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results","volume":"71","author":"Mericq","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2023071417192868200_dgad081-B52","first-page":"1241","article-title":"Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty","volume":"29","author":"Klein","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"10","key":"2023071417192868200_dgad081-B53","doi-asserted-by":"crossref","first-page":"e3660","DOI":"10.1210\/clinem\/dgaa479","article-title":"Phase 3 trial of a small-volume subcutaneous 6-month duration leuprolide acetate treatment for central precocious puberty","volume":"105","author":"Klein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071417192868200_dgad081-B54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpeds.2021.12.030","article-title":"Gonadotropin-releasing hormone analogs for treatment of central precocious puberty in children younger than 2 years of age","volume":"244","author":"Gohil","year":"2022","journal-title":"J Pediatr"},{"issue":"6","key":"2023071417192868200_dgad081-B55","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jc.2014-3031","article-title":"Long-term continuous suppression with once-yearly histrelin subcutaneous implants for the treatment of central precocious puberty: a final report of a phase 3 multicenter trial","volume":"100","author":"Silverman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023071417192868200_dgad081-B56","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.clinthera.2010.09.009","article-title":"Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists","volume":"32","author":"Miller","year":"2010","journal-title":"Clin Ther"},{"issue":"3","key":"2023071417192868200_dgad081-B57","first-page":"345","article-title":"Long-term effects and significant adverse drug reactions (ADRs) associated with the use of gonadotropin-releasing hormone analogs (GnRHa) for central precocious puberty: a brief review of literature","volume":"90","author":"De Sanctis","year":"2019","journal-title":"Acta Biomed"},{"issue":"3","key":"2023071417192868200_dgad081-B58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4274\/jcrpe.2212","article-title":"Pseudotumour cerebri presentation in a child under the gonadotropin-releasing hormone agonist treatment","volume":"8","author":"Gul","year":"2016","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"1","key":"2023071417192868200_dgad081-B59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13633-020-00092-4","article-title":"Pseudotumor cerebri in patient on leuprolide acetate for central precocious puberty","volume":"2020","author":"Omar","year":"2020","journal-title":"Int J Pediatr Endocrinol"},{"key":"2023071417192868200_dgad081-B60","author":"AAP News","year":"2022"},{"issue":"1","key":"2023071417192868200_dgad081-B61","doi-asserted-by":"crossref","DOI":"10.1186\/1687-9856-2009-812517","article-title":"Results of a second year of therapy with the 12-month histrelin implant for the treatment of central precocious puberty","volume":"2009","author":"Rahhal","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"issue":"7","key":"2023071417192868200_dgad081-B62","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jpedsurg.2018.08.048","article-title":"Histrelin implantation in the pediatric population: A 10-year institutional experience","volume":"54","author":"Swendiman","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"8","key":"2023071417192868200_dgad081-B63","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/09513590.2010.507289","article-title":"Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment","volume":"27","author":"Poomthavorn","year":"2011","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"2023071417192868200_dgad081-B64","article-title":"Gonadotropin-releasing hormone agonist therapy and obesity in girls","volume":"13","author":"Arani","year":"2015","journal-title":"Int J Endocrinol Metab"},{"issue":"11","key":"2023071417192868200_dgad081-B65","first-page":"896","article-title":"[Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study]","volume":"13","author":"Yuan","year":"2011","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"4","key":"2023071417192868200_dgad081-B66","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1210\/jc.2014-3748","article-title":"Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades","volume":"100","author":"Lazar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071417192868200_dgad081-B67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13633-016-0033-7","article-title":"Body mass index in girls with idiopathic central precocious puberty during and after treatment with GnRH analogues","volume":"2016","author":"Arcari","year":"2016","journal-title":"Int J Pediatr Endocrinol"},{"issue":"2","key":"2023071417192868200_dgad081-B68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/jpem-2018-0290","article-title":"One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty","volume":"32","author":"Arcari","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9-10","key":"2023071417192868200_dgad081-B69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1159\/000513702","article-title":"Fertility of women treated during childhood with triptorelin (depot formulation) for central precocious puberty: the PREFER study","volume":"93","author":"Martinerie","year":"2020","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2023071417192868200_dgad081-B70","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004310051289","article-title":"Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues","volume":"159","author":"Bertelloni","year":"2000","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2023071417192868200_dgad081-B71","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/jc.2004-1863","article-title":"Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese study group on central precocious puberty","volume":"90","author":"Tanaka","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023071417192868200_dgad081-B72","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.fertnstert.2008.11.016","article-title":"Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty","volume":"93","author":"Franceschi","year":"2010","journal-title":"Fertil Steril"},{"issue":"5","key":"2023071417192868200_dgad081-B73","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/cen.14410","article-title":"Long-term efficacy and safety of gonadotropin-releasing hormone analog treatment in children with idiopathic central precocious puberty: A systematic review and meta-analysis","volume":"94","author":"Luo","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2023071417192868200_dgad081-B74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-09-1102","article-title":"GNRH Analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome","volume":"163","author":"Chiavaroli","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"2023071417192868200_dgad081-B75","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1530\/eje.0.151s047","article-title":"Bone development during GH and GnRH analog treatment","volume":"151","author":"Antoniazzi","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2023071417192868200_dgad081-B76","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jpeds.2012.08.038","article-title":"Random luteinizing hormone often remains pubertal in children treated with the histrelin implant for central precocious puberty","volume":"162","author":"Lewis","year":"2013","journal-title":"J Pediatr"},{"issue":"11","key":"2023071417192868200_dgad081-B77","first-page":"1249","article-title":"Monitoring treatment of central precocious puberty using basal luteinizing hormone levels and practical considerations for dosing with a 3-month leuprolide acetate formulation","volume":"29","author":"Lee","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2023071417192868200_dgad081-B78","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2265.2011.04185.x","article-title":"Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection","volume":"76","author":"Demirbilek","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2023071417192868200_dgad081-B79","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1210\/jc.2003-031537","article-title":"A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls","volume":"89","author":"Brito","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023071417192868200_dgad081-B80","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpeds.2013.01.021","article-title":"Time to menarche and final height after histrelin implant treatment for central precocious puberty","volume":"163","author":"Gillis","year":"2013","journal-title":"J Pediatr"},{"issue":"3","key":"2023071417192868200_dgad081-B81","doi-asserted-by":"crossref","first-page":"185","DOI":"10.6065\/apem.2040220.110","article-title":"Clinical findings influencing time to menarche post gonadotropin-releasing hormone agonist therapy in central precocious puberty","volume":"26","author":"Wu","year":"2021","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"2","key":"2023071417192868200_dgad081-B82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humupd\/dmh012","article-title":"Precocious puberty and statural growth","volume":"10","author":"Carel","year":"2004","journal-title":"Hum Reprod Update"},{"issue":"10","key":"2023071417192868200_dgad081-B83","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1210\/jcem.86.10.7915","article-title":"Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience","volume":"86","author":"Klein","year":"2001","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad081\/49879478\/dgad081.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/8\/2115\/50884586\/dgad081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/8\/2115\/50884586\/dgad081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T21:59:38Z","timestamp":1702072778000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/8\/2115\/7076933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":83,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,3,14]]},"published-print":{"date-parts":[[2023,7,14]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad081","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,3,14]]}}}